Herpes Simplex Virus 1 Envelope Glycoprotein C Shields Glycoprotein D to Protect Virions from Entry-Blocking Antibodies

McKenna Hull,Suzanne M. Pritchard,Anthony V. Nicola

DOI: https://doi.org/10.1101/2024.08.20.608756

2024-08-20

Abstract:Herpes simplex virus 1 (HSV-1) gD interaction with the host cell receptor nectin-1 triggers the membrane fusion cascade during viral entry. Potent neutralizing antibodies to gD prevent receptor-binding or prevent gD interaction with gH/gL critical for fusion. HSV has many strategies to evade host immune responses. We investigated the ability of virion envelope gC to protect envelope gD from antibody neutralization. HSV-1 lacking gC was more sensitive to neutralization by anti-gD monoclonal antibodies than a wild type rescuant virus. gD in the HSV-1 gC-null viral envelope had enhanced reactivity to anti-gD antibodies compared to wild type. HSV-1 DeltagC binding to the nectin-1 receptor was more readily inhibited by a neutralizing anti-gD monoclonal antibody. HSV-1 DeltagC was also more sensitive to inhibition by soluble nectin-1 receptor. The viral membrane protein composition of HSV-1 DeltagC was equivalent to that of wild type, suggesting that the lack of gC is responsible for the increased reactivity of gD-specific antibodies and the consequent increased susceptibility to neutralization by those antibodies. Together, the results suggest that gC in the HSV-1 envelope shields both receptor-binding domains and gH/gL-interacting domains of gD from neutralizing antibodies, facilitating HSV cell entry.

Microbiology

What problem does this paper attempt to address?

The problem this paper attempts to address is whether the envelope glycoprotein C (gC) of Herpes Simplex Virus 1 (HSV-1) can protect another important envelope glycoprotein D (gD) from recognition and neutralization by neutralizing antibodies. Specifically, the researchers explored how the presence of gC in HSV-1 viral particles affects the sensitivity of gD to neutralizing antibodies and how this protective mechanism helps the virus evade the host immune system's attack.

### Main Research Content:
1. **Protective Role of gC on gD**:
- The researchers compared the neutralization sensitivity of wild-type HSV-1 (containing gC) and gC-deleted HSV-1 (ΔgC) under different concentrations of anti-gD monoclonal antibodies (MAbs).
- The results showed that HSV-1 lacking gC was more sensitive to neutralization by various anti-gD antibodies, indicating that gC indeed protects gD from antibody recognition and neutralization.

2. **Impact of gC on gD Antibody Binding**:
- Through dot blot immunoassay, the researchers found that HSV-1 lacking gC had an enhanced binding ability to various anti-gD antibodies, further supporting the protective role of gC on gD.

3. **Protective Role of gC on gD Receptor Binding**:
- The researchers also tested how the presence of gC affects HSV-1 binding to the soluble nectin-1 receptor. The results showed that HSV-1 lacking gC was more easily inhibited by anti-gD antibodies in binding to nectin-1, further proving the function of gC in protecting gD.

### Research Significance:
- **Immune Evasion Mechanism**: HSV-1 is a common pathogen that can cause lifelong infections, and there is currently no vaccine or cure. Understanding how the virus evades the host immune system's attack is key to developing effective vaccines and therapeutic strategies.
- **Vaccine Design**: As a multifunctional envelope glycoprotein, the role of gC in immune evasion suggests that including it as a vaccine candidate component may help block the virus's intrinsic protective mechanisms, thereby enhancing vaccine efficacy.

Overall, this paper reveals the mechanism by which HSV-1 uses gC to protect gD from neutralizing antibody attacks, providing new insights for developing vaccines and treatments against HSV-1.